Literature DB >> 21485069

[Modernized study on eye's signs of blood-stasis syndrome].

Rui Wu1, Jian-xiang Xie, Feng-da Zhao.   

Abstract

OBJECTIVE: To make out a computerized formula to diagnose eye's signs of blood-stasis syndrome (BSS), and to improve the previous diagnostic methods by naked eyes.
METHODS: The formula was created by detecting and analyzing the changes of eye's signs in 544 patients (261 of non-BSS and 283 of BSS) quantitatively, adopting computer's color scale principle. And the sensitivity, specificity and accuracy of the formula were verified in 382 patients (97 non-BSS and 285 of BSS). The computerized integral was compared with the naked eye integral, and the normal reference value was calculated with percentile.
RESULTS: Various observatory indices of eye's sign were positively correlated with BSS. The specificity of the computerized method was 83.5%, and the diagnostic sensitivity was 89.8%, the accuracy 88.2%, and the correct index 0.733. Comparisons between the computerized integral method and the naked eye integral method showed significant difference in patients of non-BSS or of BSS in various degrees (including mild, moderate and severe) (P < 0.01). The reference value of the naked eye method was below 15.
CONCLUSION: The computerized formula of eye's signs has higher specificity and sensitivity in the diagnosis of BSS, while the naked eye integral method is proved to be useful.

Entities:  

Mesh:

Year:  2011        PMID: 21485069

Source DB:  PubMed          Journal:  Zhongguo Zhong Xi Yi Jie He Za Zhi        ISSN: 1003-5370


  2 in total

1.  Role of eye's sign in patients with neuropsychiatric disorders of systemic lupus erythematosus.

Authors:  Rui Wu
Journal:  Rheumatol Int       Date:  2013-06-18       Impact factor: 2.631

2.  Metabolomic analysis of clinical plasma from cerebral infarction patients presenting with blood stasis.

Authors:  Min Ho Cha; Min Jung Kim; Jeeyoun Jung; Jin Hee Kim; Myeong Soo Lee; Myung-Sunny Kim
Journal:  Evid Based Complement Alternat Med       Date:  2015-03-05       Impact factor: 2.629

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.